Summary
abrdn U.S. Small Cap Equity Fund is a mutual fund. It does not trade on an exchange: you buy it from the fund company at a price set once a day. Positions inside: 59. The ten largest make up 125% of the fund.
- Positions
- 59
- Dividends
- Reinvested
What speaks for it
- Average yearly growth over the last ten years: 13%.
What to watch
- The ten largest positions make up 125% of the fund, so its result rests on a few names.
- In the last five years its price once dropped by 32% from its high.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -0.6%
- 3 months
- -6.6%
- This year
- +16%
- 1 year
- +16%
- 3 years
- +74%
- 5 years
- +48%
- 10 years
- +233%
- Avg. market cap
- $4.32B
- P/E
- 19.8x
- Forward P/E
- 17.6x
- P/S
- 1.1x
- P/B
- 2.8x
- P/FCF
- 13.6x
- EV/EBITDA
- 15.5x
- Dividend yield
- 0.75%
- ROIC
- 8.0%
- ROE
- 16.1%
- Gross margin
- 45.6%
- Operating margin
- 13.6%
- Net margin
- 10.6%
- Payout ratio
- 14.8%
- Net debt/EBITDA
- 16.1x
- Beta
- 1.05
Weighted average of the 50 largest companies, which make up 92% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 Total 100%
- 2 MGMagnolia Oil & Gas Corporation MGY 3.0%
- 3 QTQ2 QTWO 2.9%
- 4 KINIKSA PHARMACEUTICALS INTE 2.8%
- 5 WSWSFS Financial Corporation WSFS 2.8%
- 6 SBSeacoast Banking Corporation of Florida SBCF 2.7%
- 7 WTWintrust Financial Corporation WTFC 2.7%
- 8 CWCasella Waste Systems CWST 2.6%
- 9 ANANI Pharmaceuticals, Inc. ANIP 2.6%
- 10 TVTravere Therapeutics, Inc. TVTX 2.5%
Positions in the fund: 59. The ten largest make up 125% of it.
Composition as of Oct 8, 2026.
Where is it spread?
By company size
- Large cap 3.4%
- Mid cap 87%
- Small cap 9.7%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest size group: Mid cap (87%).
What does it cost me?
We do not know the costs of this fund.
How has it done?
Growing over the long run- A year on average, 10 years
- +13%
- Deepest drop
- -32%
- Yearly volatility
- 18%
Average yearly growth over the last ten years: 13%. Deepest drop in these years: 32% below the earlier high.
Does it pay dividends?
No, it reinvestsThe fund pays nothing out. What its holdings earn stays inside and shows in the price.
How expensive are the companies inside?
Usual valuation- P/E of the companies inside
- 19.8
- Average Bulios Score
- 60 out of 100
Weight by Bulios Fair Price
- Undervalued 29%
- Fairly valued 7.7%
- Overvalued 63%
On average the companies inside trade for 19.8 times their yearly profit. By Fair Price, 63% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 92% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Can I buy it as an ETF?
A mutual fund is bought from the fund company. These ETFs hold much of the same and trade on an exchange, so an ordinary broker carries them.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
AF AFSC abrdn Focused U.S. Small Cap Active ETF | United States | 1.09% | $80.9M | +21% | Pays out | 72% |